$18B+ in Cross-Border M&A: What the Merck KGaA and ON Semiconductor Deals Signal for Corporate Finance in 2025
Merck KGaA’s $11.3B acquisition of Bio-Techne and ON Semiconductor’s $7B all-stock deal for Synaptics signal a new wave of capability-driven cross-border M&A in life sciences and AI hardware. Decision-makers should prepare for expanded due diligence scope, longer regulatory timelines, and a sharper focus on post-merger integration discipline.